- Fee assured
- Awaiting verification
- Cardiac devices
- Devices: cardiac resynchronisation therapy device (CRT)
- Devices: implantable cardioverter defibrillator (ICD)
- Devices: single chamber pacemaker insertion
- Electrophysiology complex cardiac ablation
- Electrophysiology simple cardiac ablation
Dr Elijah Behr is a clinical cardiologist and electrophysiologist with an interest in all aspects of the treatment of arrhythmias including ablation and device therapies and cardiac genetic disorders. He completed his medical education at St John's College, Cambridge and Guy's Hospital, London with distinction. He was appointed to his current role in 2007 having undertaken full time clinical training and research at St George's.
Dr Behr is an international expert in the management of patients and families with cardiac genetic disorders that can cause sudden death - sudden arrhythmic death syndrome (SADS) . He is secretary of the Association for Inherited Cardiac Conditions and is UK lead on the International Guidelines Writing Committee member. He co-leads research in the 100,000 genomes project on inherited heart rhythm disturbances.
Areas of interest
Arrhythmias; Cardiac electrophysiology; Ablation; Cardiomyopathy; Sudden arrhythmic death syndrome; SADS; Syncope; Blackouts; Brugada syndrome; Long QT syndrome; ARVC; HCM; CPVT; catecholaminergic polymorphic ventricular tachycardia; hypertrophic cardiomyopathy; arrhythmogenic right ventricular cardiomyopathy
- Carrie Victor-Smith
- Cardiovascular Sciences Research Centre St George's University of London Cranmer Terrace LONDON SW17 0RE
- 020 8725 5939
- 020 8725 3328
Anaesthetists worked with (Bupa members, please ask your consultant whether your anaesthetist is fee-assured)
- The Association of Inherited Cardiac Conditions AICC
- St George's Univerity of London
- Research Gate profile
Current NHS consultant posts held
Dr Behr is a Consultant Cardiologist at St George's Hospital specialising in cardiac electrophysiology and Reader in Cardiovascular Medicine at St George's University of London.
Dr Behr runs an arrhythmia service to manage and treat heart rhythm disorders. He also runs a nationally reputed multi-disciplinary clinical service to diagnose and treat families with sudden arrhythmic death syndrome (SADS) and inherited heart diseases.
Dr Behr's research focus is the genetic, electrophysiological, clinical, epidemiological, and pathological investigation of sudden death. He has particular interests in Brugada syndrome, long QT syndrome and cardiomyopathies as well as sudden arrhythmic death syndrome (SADS). His aim is to develop new methods for risk stratification and prevention of sudden death.
2013 Writing Member for HRS/EHRA/APHRS International Guidelines for Diagnosis and Management of Arrhythmia Syndromes
2013 Editorial Board Member, Heart Rhythm Journal, USA
2012 Visiting Professor of Cardiology, Rigshospitalet, Copenhagen University, Denmark
Many international speaking invitations at meetings of learned societies in the USA, Europe and Asia-Pacific .
Top 10 of 157 Articles
Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes:document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES,and AEPC in June 2013. Heart Rhythm. 2013 Dec;10(12):1932-63.
Wilde AA, Behr ER. Genetic testing for inherited cardiac disease. Nature Rev Cardiol. 2013 Oct;10(10):571-83.
Behr E, Wood DA, Wright M, et al; Sudden Arrhythmic Death Syndrome Steering Group. Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. the Lancet. 2003 Nov 1;362(9394):1457-9..
Makita N, Behr E, Shimizu W, et al. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest. 2008 Jun;118(6):2219-29.
Nademanee K, Raju H, de Noronha SV, ….., Behr ER. Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome. J Am Coll Cardiol. 2015 Nov 3;66(18):1976-86.
Jamshidi Y, Nolte IM, Dalageorgou C, ….., Behr ER. Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia. J Am Coll Cardiol. 2012 Aug 28;60(9):841-50.
Raju H, Papadakis M, Govindan M, Bastiaenen R, Chandra N, O'Sullivan A, Baines G, Sharma S, Behr ER. Low prevalence of risk markers in cases of sudden death due to Brugada syndrome relevance to risk stratification in Brugada syndrome. J Am Coll Cardiol. 2011 Jun 7;57(23):2340-5.
Behr ER, Dalageorgou C, Christiansen M, et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J. 2008 Jul;29(13):1670-80.
Wong LC, Roses-Noguer F, Till JA, Behr ER. Cardiac Evaluation of Pediatric Relatives in Sudden Arrhythmic Death Syndrome (SADS): A 2-Center Experience Circulation AE. 2014 Sep 6.
Behr ER, Ritchie MD, Tanaka T, et al. Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes. PLoS One. 2013 Nov 6;8(11):
- BA Honours Cambridge University 1990
- MBBS Honours London University 1993
- MA Honours Cambridge University 1993
- MD London University 2005
Professional bodies (positions held - last 3 yrs)
- Council Member and Secretary Association of Inherited Cardiac Conditions 2013
- Representative to UKCPN Heart Rhythm UK 2013
- Cardiovascular GECIP subdomain co-lead for the 100,000 genomes project St George's Univerity of London 2014
Details of entry to specialist register
- Cardiology, 2007
Affiliations / memberships
Fellowship of the Royal College of Physicians, London
Member of Heart Rhythm UK
Member of European Heart Rhythm Association
Council the Association of Inherited Cardiac Conditions
- Department of Cardiology St George's Hospital...
- 09:00 - 11:00
- 020 8725 5939
- Surrey Cardiovascular Clinic
- 17:00 - 20:00
- 01483 467100
- The New Malden Diagnostic Centre
- 17:00 - 20:00
- 020 3277 0160
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
0208 725 5939